Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM).
McComish JS, Slade CA, Buizen L, Paul SK, Chatelier JW, Unglik G, Nicholls KA, Spriggs K, Chan SS, Godsell J, Auyeung P, Tan ZH, DeLuca J, Patel M, Kuek LE, Tran Y, Kern JS, Scardamaglia L, Varigos GA, Juneja S, Grabek JA, Christie M, Mackay GA, Douglass JA.
McComish JS, et al.
J Allergy Clin Immunol Pract. 2023 Jul;11(7):2248-2250.e3. doi: 10.1016/j.jaip.2023.04.008. Epub 2023 Apr 23.
J Allergy Clin Immunol Pract. 2023.
PMID: 37088371
Clinical Trial.
No abstract available.